| 专论编号 | 物质名称 | 证书持有人 | 持有人ORG-ID和LOC-ID | 证书编号 | 发布日期 | 证书状态 | 到期续期 | 证书结束日期 | 证书类型 | 上一程序的结束日期 | 历史数据 程序类型|结论|日期 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2126 | Cefepime dihydrochloride monohydrate, Sterile | ACS DOBFAR S.P.A. Tribiano IT | 100011589;100019524 | CEP 2023-021 - Rev 01 | 2025/11/19 | Valid | 27/07/2028 | Chemical | 2025/11/19 | Major revision|CEP granted|19/11/2025; New application|CEP granted|27/07/2023 |
|
| 1131 | Methylprednisolone hydrogen succinate | HENAN LIHUA PHARMACEUTICAL CO., LTD. Anyang CN | 100016183;100024971 | CEP 2024-159 - Rev 00 | 2025/11/17 | Valid | 17/11/2030 | Chemical | 2025/11/17 | New application|CEP granted|17/11/2025 | |
| 3095 | Dabigatran etexilate mesilate | AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad IN | 100046306;100076393 | CEP 2023-382 - Rev 00 | 2025/11/17 | Valid | 17/11/2030 | Chemical | 2025/11/17 | New application|CEP granted|17/11/2025 | |
| 559 | Mannitol, For use in the manufacture of parenteral preparations | CARGILL S.R.L. Castelmassa IT | 100049176;100083235 | CEP 2005-019 - Rev 04 | 2025/11/17 | Valid | Chemical | 2025/11/17 | Minor revision|CEP granted|17/11/2025; Notification|CEP granted|24/06/2025 |
||
| 2932 | Rivaroxaban | Changzhou Pharmaceutical Factory Changzhou CN | 100012704;100018611 | CEP 2021-252 - Rev 01 | 2025/11/17 | Valid | 12/09/2027 | Chemical | 2025/11/17 | Minor revision|CEP granted|17/11/2025; Notification|Accepted - CEP remains valid|20/12/2023; New application|CEP granted|12/09/2022 |
|
| 687 | Salbutamol sulfate, Micronised | VAMSI LABS LIMITED Solapur IN | 100014747;100096958 | CEP 2024-328 - Rev 00 | 2025/11/17 | Valid | 17/11/2030 | Chemical | 2025/11/17 | New application|CEP granted|17/11/2025 | |
| 524 | Promethazine hydrochloride | EMCURE PHARMACEUTICALS LIMITED Pune IN | 100011677;100022690 | CEP 2024-304 - Rev 00 | 2025/11/17 | Valid | 17/11/2030 | Chemical | 2025/11/17 | New application|CEP granted|17/11/2025 | |
| 1336 | Ivermectin, Code iverm11 | ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. Taizhou City CN | 100011825;100018687 | CEP 2025-175 - Rev 01 | 2025/11/17 | Valid | 22/08/2030 | Chemical | 2025/11/17 | Minor revision|CEP granted|17/11/2025; New application|CEP granted|22/08/2025 |
|
| 2541 | Quetiapine Fumarate, Form-I | HETERO LABS LIMITED Hyderabad IN | 100011681;100018664 | CEP 2015-153 - Rev 04 | 2025/11/17 | Valid | Chemical | 2025/11/17 | Notification|CEP granted|17/11/2025; Minor revision|Accepted - CEP remains valid|22/08/2025; Minor revision|CEP granted|05/12/2024; Minor revision|Accepted - CEP remains valid|28/11/2023; Minor revision|CEP granted|15/06/2023; Minor revision|CEP granted|26/10/2022; Renewal|CEP granted|05/04/2022; Major revision|CEP granted|04/11/2021; Minor revision|Rejected|22/02/2021 |
||
| 1670 | Glutathione | SHANDONG JINCHENG BIO-PHARMACEUTICAL CO. LTD. Zibo CN | 100039047;100061447 | CEP 2024-255 - Rev 00 | 2025/11/17 | Valid | 17/11/2030 | Chemical | 2025/11/17 | New application|CEP granted|17/11/2025 | |
| 1012 | Famotidine, FM3 Process | IPCA LABORATORIES LIMITED Mumbai IN | 100011685;100018680 | CEP 2022-213 - Rev 02 | 2025/11/14 | Valid | 18/01/2028 | Chemical | 2025/11/14 | Minor revision|CEP granted|14/11/2025; Minor revision|CEP granted|20/10/2023; New application|CEP granted|18/01/2023 |
|
| 2191 | Atorvastatin calcium, Form-I | HETERO LABS LIMITED Hyderabad IN | 100011681;100018664 | CEP 2018-049 - Rev 04 | 2025/11/14 | Valid | Chemical | 2026/01/26 | Notification|Accepted - CEP remains valid|26/01/2026; Minor revision|CEP granted|14/11/2025; Renewal|CEP granted|19/05/2025; Minor revision|Accepted - CEP remains valid|19/08/2024; Major revision|CEP granted|26/04/2024; Monograph revision|CEP granted|24/03/2023; Major revision|Rejected|28/03/2022 |
||
| 1653 | Potassium clavulanate, diluted, Microcrystalline cellulose 1:1 blend | SMITHKLINE BEECHAM LIMITED Irvine GB | 100000119;100003201 | CEP 2005-244 - Rev 02 | 2025/11/14 | Valid | Chemical | 2025/11/14 | Minor revision|CEP granted|14/11/2025; Minor revision|Accepted - CEP remains valid|30/09/2020 |
||
| 2787 | Esomeprazole magnesium dihydrate | LEE PHARMA LIMITED Hyderabad IN | 100014849;100042625 | CEP 2021-334 - Rev 01 | 2025/11/14 | Valid | 03/05/2027 | Chemical | 2025/11/14 | Minor revision|CEP granted|14/11/2025; New application|CEP granted|03/05/2022 |
|
| 388 | Dexamethasone | TIANJIN TIANYAO PHARMACEUTICALS CO., LTD. Tianjin CN | 100011805;100018616 | CEP 2015-205 - Rev 01 | 2025/11/14 | Valid | Chemical | 2025/11/14 | Minor revision|CEP granted|14/11/2025; Renewal|CEP granted|16/08/2021 |
||
| 1484 | Levocabastine hydrochloride, Process Part 2 | KATSURA CHEMICAL CO., LTD. Zama JP | 100025070;100034253 | CEP 2018-217 - Rev 02 | 2025/11/14 | Valid | Chemical | 2025/11/14 | Minor revision|CEP granted|14/11/2025; Renewal|CEP granted|02/09/2024; Minor revision|Accepted - CEP remains valid|02/09/2022 |
||
| 1408 | Cilastatin sodium, Sterile | SHANDONG ANHONG PHARMACEUTICAL CO., LTD. Dezhou CN | 100014777;100050265 | CEP 2025-103 - Rev 00 | 2025/11/14 | Valid | 14/11/2030 | Chemical | 2025/11/14 | New application|CEP granted|14/11/2025 | |
| 576 | Allopurinol, Site-II | HETERO DRUGS LIMITED Hyderabad IN | 100008415;100014434 | CEP 2025-441 - Rev 00 | 2025/11/14 | Valid | 14/11/2030 | Chemical | 2025/11/14 | New application|CEP granted|14/11/2025 | |
| 3132 | Mirabegron | MEGAFINE PHARMA PRIVATE LIMITED Mumbai IN | 100011550;100021133 | CEP 2024-087 - Rev 02 | 2025/11/14 | Valid | 28/03/2030 | Chemical | 2025/11/14 | Administrative procedure|CEP granted|14/11/2025; Major revision|CEP granted|03/11/2025; New application|CEP granted|28/03/2025 |
|
| 1688 | Articaine hydrochloride | SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL CO., LTD. Dezhou City CN | 100048410;100080174 | CEP 2023-255 - Rev 01 | 2025/11/13 | Valid | 03/01/2030 | Chemical | 2025/11/13 | Minor revision|CEP granted|13/11/2025; New application|CEP granted|03/01/2025 |
请输入需要查询的英文物质名称,证书持有人,证书编号,专论编号